MYUNGMOON Pharm co.,Ltd (KRX:017180)

MYUNGMOON Pharm co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8,430	4,392	7,962	4,858	6,813	4,553
Short-Term Investments	235	350	3,650	5,065	3,620	6,218
Trading Asset Securities	14.86	15.41	52.65	61.67	83.95	2,317
Cash & Short-Term Investments	8,680	4,758	11,664	9,984	10,517	13,088
Cash Growth	-26.24%	-59.21%	16.83%	-5.06%	-19.65%	54.24%
Accounts Receivable	43,702	38,091	33,489	29,456	27,530	29,848
Other Receivables	3,508	4,044	4,243	3,606	2,171	5,229
Receivables	47,209	42,172	38,846	34,673	30,281	35,556
Inventory	37,637	32,685	30,280	25,660	26,032	30,246
Prepaid Expenses	130.89	210.07	189.83	184.71	504.29	1,424
Other Current Assets	325.25	505.1	455.72	205.58	132.32	263.02
Total Current Assets	93,982	80,329	81,436	70,707	67,466	80,577
Property, Plant & Equipment	162,571	161,994	140,196	141,777	142,861	149,944
Long-Term Investments	2,902	3,431	1,540	4,457	3,245	2,156
Goodwill	-	-	-	-	-	434.42
Other Intangible Assets	535.94	528.86	267.49	318.47	247.39	330.03
Long-Term Deferred Tax Assets	5,000	6,175	8,109	8,168	4,273	4,273
Other Long-Term Assets	5,432	5,222	5,001	5,022	5,170	5,254
Total Assets	270,732	257,988	236,549	230,450	223,263	243,025
Accounts Payable	18,012	17,382	16,746	15,677	13,633	15,905
Accrued Expenses	17,034	17,031	16,349	11,848	12,124	9,658
Short-Term Debt	41,077	42,114	74,607	73,503	75,657	82,397
Current Portion of Long-Term Debt	12,672	9,686	1,907	1,306	1,269	7,624
Current Portion of Leases	134.94	376.13	922.99	1,045	1,249	1,071
Current Income Taxes Payable	54.63	47.47	-	118.42	164.35	948.76
Other Current Liabilities	6,615	6,023	5,840	7,325	8,992	7,717
Total Current Liabilities	95,600	92,660	116,373	110,821	113,088	125,320
Long-Term Debt	41,293	35,255	12,584	6,092	4,957	6,388
Long-Term Leases	26.13	74.33	460.2	1,212	998.7	1,314
Long-Term Deferred Tax Liabilities	6,436	6,436	3,521	3,521	3,706	3,706
Other Long-Term Liabilities	4,197	2,707	1,652	270.67	827.67	523.19
Total Liabilities	166,382	154,865	147,794	135,182	137,389	152,250
Common Stock	16,977	16,977	16,977	16,977	16,977	16,977
Additional Paid-In Capital	35,178	35,178	35,178	35,178	77,313	77,171
Retained Earnings	2,036	564.41	6,031	11,425	-39,976	-33,723
Treasury Stock	-1,471	-1,471	-1,215	-540.01	-540.01	-540.01
Comprehensive Income & Other	45,603	45,603	26,483	26,483	26,483	27,317
Total Common Equity	98,323	96,851	83,453	89,522	80,257	87,201
Minority Interest	6,028	6,271	5,302	5,745	5,617	3,574
Shareholders' Equity	104,350	103,123	88,755	95,267	85,874	90,775
Total Liabilities & Equity	270,732	257,988	236,549	230,450	223,263	243,025
Total Debt	95,204	87,505	90,482	83,157	84,130	98,794
Net Cash (Debt)	-86,524	-82,748	-78,818	-73,173	-73,614	-85,706
Net Cash Per Share	-2590.14	-2471.19	-2340.26	-2164.50	-2177.55	-2927.71
Filing Date Shares Outstanding	33.43	33.43	33.53	33.81	33.81	33.81
Total Common Shares Outstanding	33.43	33.43	33.53	33.81	33.81	33.81
Working Capital	-1,617	-12,330	-34,937	-40,115	-45,622	-44,743
Book Value Per Share	2941.30	2897.28	2489.11	2648.13	2374.06	2579.48
Tangible Book Value	97,787	96,322	83,186	89,204	80,010	86,437
Tangible Book Value Per Share	2925.26	2881.46	2481.14	2638.71	2366.74	2556.86
Land	100,264	100,264	74,397	74,397	74,726	77,436
Buildings	61,197	61,197	61,545	58,194	58,325	59,310
Machinery	34,648	33,266	32,325	30,828	29,991	33,626
Construction In Progress	4,399	2,191	2,191	3,418	2,365	2,949

Source: S&P Global Market Intelligence. Standard template. Financial Sources.